ANDA 72630, held by Watson Laboratories. Albuterol Sulfate.
As of Nov 21, 2026, ANDA 72630 (Albuterol Sulfate), held by Watson Laboratories, was first approved by FDA on Jan 31, 1991, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 31, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 4MG BASE · tablet;oral | Albuterol Sulfate | Discontinued |
| Feb 1, 1993 | Supplement 2Labeling | Approved | None posted |
| Oct 21, 1991 | Supplement 1Manufacturing | Approved | None posted |
| Jan 31, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters